OMG.... WHAT A HISTORIC BOTTOM RIGHT NOW
What up with that? I know under FDASIA you don't need one
Not a dmd partner but i would think a different muscle disease partner in Europe where they payed some and gave us a 10 percent fee on every sale and then gave up all the rights and data for U.S. approval for us to have.
I faxed Ed Kaye a letter a while back asking him to re-do patents ''just in case '' to have them implying to PMO_S creating mechanisms of action to skip exons and anyway that is how it should be based. for example pmo-s are one action and other antisenses would be their own..Patents standing on their own merit as they are and no patent interference . Some patents out there are saying they own exons in a certain way and exons are part of a gene.
The offering was very small but needed for drug launch and other exons drugs. @ 39.00 a share already agreed ,expect to be in the high forties this month.
Cash is King,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bad timing and the whole biotech stocks such because of the FEDS and certain others...look at many small biotechs well below 85 week lows....
many small caps are well below 52 week lows and biotech was the only real growth left out there????
this is very strange...
you got to sell at a deal and get those good brokers on your side.you must meet FDA guidelines before a drug launch as well. 250 mil in the bank looks good before a drug approval ,plus a 350 mil drug voucher..think about it.
Watch what goes on the next 60 days...........
keep your eyes open ,this one is different....To launch a drug you must meet a certain standard ''per FDA'' The drug approval must be a done deal''
you must have the resources to launch drugs per FDA ..exon 51 and others plus grow real fast.